Trinity Biotech Capital Expenditures (CapEx) Growth & History (TRIB)

Trinity Biotech's capital expenditures (capex) was $6.2M for fiscal 2025.

View full Trinity Biotech company overview

Trinity Biotech annual capital expenditures (capex) history

Trinity Biotech annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$6.2M$5.8M+1436.54%
20242024-12-31$405,000−$398,000−49.56%
20232023-12-31$803,000−$298,000−27.07%
20222022-12-31$1.1M−$711,000−39.24%
20212021-12-31$1.8M−$1.4M−42.98%
20202020-12-31$3.2M$1.1M+50.05%
20192019-12-31$2.1M−$5.4M−71.87%
20182018-12-31$7.5M$2.7M+55.57%
20172017-12-31$4.8M$624,000+14.80%
20162016-12-31$4.2M−$2.9M−40.58%
20152015-12-31$7.1M

Trinity Biotech capital expenditures (capex) trends

Over the last five fiscal years, Trinity Biotech's capital expenditures (capex) increased from $3.2M to $6.2M, a change of $3.0M. The latest reported quarter, Q4 2024, shows $2.7M.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Trinity Biotech source filings ↗

Community posts

It’s quiet here.

No posts about TRIB yet. Start the conversation.

Write the first post